piperonyl butoxide has been researched along with Disease Models, Animal in 6 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, values of time to reach the concentration maximum (normal and calculated), area under the concentration-time curve (0-∞ and calculated), minimum residence time, distribution half-life, elimination half-life and total area under the first movement of plasma drug concentration-time curve were significantly higher (P < 0." | 1.43 | Efficacy of pharmacokinetic interactions between piperonyl butoxide and albendazole against gastrointestinal nematodiasis in goats. ( Kerketta, AE; Kumar, D; Kumbhakar, NK; Pal, S; Rawte, D; Sanyal, PK, 2016) |
| "Phenobarbital (PB) is a cytochrome P450 (CYP) 2B inducer, and piperonyl butoxide (PBO) is a CYP1A/2B inducer." | 1.39 | Suppressive effect of liver tumor-promoting activities in rats subjected to combined administration of phenobarbital and piperonyl butoxide. ( Akane, H; Itahashi, M; Mitsumori, K; Morita, R; Nakane, F; Shibutani, M; Shiraki, A; Suzuki, K; Yafune, A, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Morita, R | 1 |
| Yafune, A | 1 |
| Shiraki, A | 1 |
| Itahashi, M | 1 |
| Akane, H | 1 |
| Nakane, F | 1 |
| Suzuki, K | 1 |
| Shibutani, M | 1 |
| Mitsumori, K | 1 |
| Sakamoto, Y | 1 |
| Yoshida, M | 2 |
| Tamura, K | 1 |
| Takahashi, M | 1 |
| Kodama, Y | 1 |
| Inoue, K | 2 |
| Kumbhakar, NK | 1 |
| Sanyal, PK | 1 |
| Rawte, D | 1 |
| Kumar, D | 1 |
| Kerketta, AE | 1 |
| Pal, S | 1 |
| Nemoto, K | 1 |
| Tanaka, T | 1 |
| Ikeda, A | 1 |
| Ito, S | 1 |
| Mizukami, M | 1 |
| Hikida, T | 1 |
| Gamou, T | 1 |
| Habano, W | 1 |
| Ozawa, S | 1 |
| Nishikawa, A | 1 |
| Degawa, M | 1 |
| Veronesi, B | 1 |
6 other studies available for piperonyl butoxide and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Suppressive effect of liver tumor-promoting activities in rats subjected to combined administration of phenobarbital and piperonyl butoxide.
Topics: Animals; Carcinoma, Hepatocellular; Cell Proliferation; Cytochrome P-450 CYP1A1; Depression, Chemica | 2013 |
Dose-dependent difference of nuclear receptors involved in murine liver hypertrophy by piperonyl butoxide.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cyto | 2015 |
Efficacy of pharmacokinetic interactions between piperonyl butoxide and albendazole against gastrointestinal nematodiasis in goats.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Disease Models, Animal; Drug Interactions | 2016 |
Super-induced gene expression of the N-methyl-D-aspartate receptor 2C subunit in chemical-induced hypertrophic liver in rats.
Topics: Animals; Clofibrate; Disease Models, Animal; Gene Expression; Hepatomegaly; Liver; Male; Oligonucleo | 2011 |
Effect of metabolic inhibition with piperonyl butoxide on rodent sensitivity to tri-ortho-cresyl phosphate.
Topics: Animals; Biotransformation; Chemical and Drug Induced Liver Injury; Cresols; Disease Models, Animal; | 1984 |